Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01553071
Title Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Age Groups: adult
Covered Countries USA

No variant requirements are available.